KeyBioscience Announces Extension of Strategic Collaboration with Lilly

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

KEYBIOSCIENCE-Lilly

More Like This

Camurus announces expansion of Lilly collaboration

OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies

Keymed Biosciences Announces 2025 Annual Results and Business Updates

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Debiopharm to Unveil New Pre-Clinical and Clinical Research Advances in DDR Inhibition, Dual Payload ADCs, and AI-Driven Biomarkers at AACR 2026

CORRECTING and REPLACING Altasciences Supports Metsera in Their Early-Stage Clinical Trials for Obesity

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

AACR 2026: Crown Bioscience Showcases Integrated Platforms Enabling Next-Generation Oncology Modalities, Including ADCs and Radiopharmaceuticals